Successful topical treatment of sorafenib-induced hand-foot skin reaction in a child with hepatocellular carcinoma.
Pediatr Dermatol
; 26(3): 349-50, 2009.
Article
em En
| MEDLINE
| ID: mdl-19706105
ABSTRACT
Orally active kinase inhibitors such as Sorafenib are known to elicit cutaneous side effects in the majority of adult patients, whereas specific cutaneous complications of this agent have not been described in children so far. We here present the first pediatric case of Sorafenib-induced hand-foot-skin reaction and its successful topical therapy facilitating continuation of kinase inhibitor treatment.
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Piridinas
/
Benzenossulfonatos
/
Carcinoma Hepatocelular
/
Inibidores de Proteínas Quinases
/
Dermatoses do Pé
/
Dermatoses da Mão
/
Neoplasias Hepáticas
/
Antineoplásicos
Idioma:
En
Ano de publicação:
2009
Tipo de documento:
Article